STAT

SEPTEMBER 21, 2023

And who decides what’s good enough for patients in need? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Can the FDA be too flexible? How do you test a mechanical womb? Read the rest…

260

260

STAT

SEPTEMBER 21, 2023

My experiences caring for these patients are not unique. Over the past year, my colleagues and I at “ The Nocturnists ,” a health care worker storytelling podcast, have been interviewing abortion providers across the country for our new series “ Post-Roe America ,” which debuts Thursday.

360

360

STAT

JUNE 28, 2023

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months.

241

241

Pharma Marketing Network

OCTOBER 27, 2021

Tune in to listen to PMN Editorial Advisory Board Member (EAB), Darshan Kulkarni, discuss the conflicts of interest in relation to patient advocacy, with his guest Dr. Alison Bateman-House, Research Assistant Professor of Medical Ethics at NYU School of Medicine, during an episode on the DarshanTalks podcast. Funding for these groups.

40

40

STAT

NOVEMBER 16, 2023

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability.

204

204

STAT

DECEMBER 8, 2022

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT’s Elaine Chen joins us to explain how the escalating demand for a potent diabetes drug is putting patients with obesity in a difficult situation. And what happens when sweetheart deals go bad?

Diabetes 231

Diabetes 231

pharmaphorum

FEBRUARY 27, 2024

Next-generation technology is enabling drug discovery at an entirely new scale, accelerating the process, transforming therapies and advancing precision medicine, and resulting in better patient outcomes. In this podcast, Dr Mohit Jain, founder and CEO of Sapient, discusses personalised disease prediction, diagnostics, and therapies.

113

113

STAT

AUGUST 18, 2023

“T he Retrievals,” a disturbing podcast from Serial and the New York Times released this summer, painstakingly tells the stories of women who sought fertility treatments at the Yale Fertility Center in 2020. This is not the first time a health care worker has diverted pain medications away from patients.

244

244

STAT

JULY 26, 2023

” In fact, Florida legislators recently passed a law that would limit who gets to introduce themselves to patients as “doctors.” But as part of a fight over “scope creep” in health care, many medical doctors might bristle at the idea of calling Edmonds “doctor.” ” (Gov.

195

195

STAT

MARCH 16, 2023

Is AI dictating patient care? We cover all that and more this week on the 250th episode of “The Readout LOUD,” STAT’s biotech podcast. What happens when your bank falls apart? And can Illumina endure some shareholder activism?

209

209

STAT

APRIL 20, 2023

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Then we dive into the long history of a gene therapy from Sarepta Therapeutics, a polarizing medicine that promises to change the lives of patients with Duchenne muscular dystrophy.

Vaccines 226

Vaccines 226

pharmaphorum

JANUARY 9, 2024

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.

Drug Development 117

Drug Development 117

STAT

FEBRUARY 23, 2023

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT’s Ed Silverman joins us to explain how an escalating fight between Vertex Pharmaceuticals and insurance companies has left patients and families caught in the middle.

Vaccines 188

Vaccines 188

STAT

JULY 12, 2023

Last month, t he FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

211

211

pharmaphorum

FEBRUARY 20, 2024

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpour, co-founder and CEO of SEQSTER, about their latest partnership, with its goal of personalised registries and the notion of the digital front door for patient information.

103

103

STAT

DECEMBER 15, 2022

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Katie Palmer, STAT’s health tech correspondent, joins us to explain how the explosive popularity of telehealth is putting sensitive patient information into the hands of Facebook, TikTok, and other big tech firms.

184

184

pharmaphorum

NOVEMBER 17, 2022

In this mini episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Sylvana Sinha, founder, chair, and CEO of Praava Health, Bangladesh’s fastest growing healthcare brand. Praava Health is a patient-driven company disrupting the standard of healthcare for Bangladesh’s 170 million citizens. No mean feat.

98

98

Safe Biologics

SEPTEMBER 6, 2023

On September 6th, AI Arthritis released Episode 88 of its AI Arthritis 360 Talk Show , in which ASBM representatives discuss potential policy changes regarding interchangeable biosimilars and how they may undermine the patient protections currently in place. Listen to the podcast (audio file)

Biosimilars 130

Biosimilars 130

pharmaphorum

DECEMBER 1, 2022

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock chats with Gita Barry, EVP and GM of Immersive Healthcare at Penumbra, a therapeutic VR company. Gita discusses how the full control over the environment that VR gives can help a PT patient to feel more comfortable and make gradual progress toward their goals.

98

98

pharmaphorum

DECEMBER 30, 2022

Chatting about Graphite Digital’s role as a design specialist for HCPs, patient groups, and ‘everything in between’ – the vision and purpose that encircles that – Verheul and I look at the conversations being sparked at the event, the challenges that are clear across industries, and the collaborative efforts that are now required.

97

97

pharmaphorum

DECEMBER 28, 2023

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.

62

62

pharmaphorum

OCTOBER 20, 2022

This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly. The post Live from Reuters Pharma 2022 – the pharmaphorum podcast appeared first on.

97

97

Pharmacy Times

FEBRUARY 28, 2024

The podcast highlights addressing misinformation, the impact of celebrity endorsements in pharmaceuticals, and the important role of pharmacists in educating patients.

52

52

Pharmacy Times

MARCH 13, 2024

This podcast episode discussed the impact of celebrity endorsements on trends in weight loss drugs like Ozempic, body image issues, and the role of pharmacists in educating patients on appropriate use of GLP-1 medications for weight management and chronic diseases.

55

55

pharmaphorum

JANUARY 14, 2022

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. About the interviewees.

Communication 98

Communication 98

pharmaphorum

NOVEMBER 3, 2022

In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang to better understand why big tech’s ventures into healthcare seem to stumble more often than not. The post The pharmaphorum podcast: Why is digital health so challenging for big tech? appeared first on.

98

98

Safe Biologics

JANUARY 12, 2024

The episode features three former government officials who worked on the development and implementation of Medicare Part D as well as two leading patient advocates. View video of the podcast here. Read ASBM’s full comments to the Oregon PDAB here. Proposing to change this standard in the U.S.

Biosimilars 130

Biosimilars Drug Pricing 130

pharmaphorum

DECEMBER 29, 2022

Join editor-in-chief Jonah Comstock, founder Paul Tunnah, Deep Dive editor Eloise McLennan, and web editor Nicole Raleigh for a wide-ranging discussion touching on clinical trials, patient centricity, COVID-19’s impact on digital health, precision medicine, and artificial intelligence and machine learning. .

52

52

Pharmaceutical Commerce

DECEMBER 5, 2023

In today’s podcast we talk with Ron Lacy, Vice President of Product and Innovation from UBC about how AI is changing the services in the patient services market.

52

52

pharmaphorum

OCTOBER 6, 2022

Dr Marie-Louise Fjällskog, chief medical officer at Faron Pharmaceuticals, joins host Jonah Comstock for the pharmaphorum podcast this week to give us a primer on the TME, what it is, how we understand it, and what it means for the future of cancer care.

Immunity 52

Immunity Immunization Drug Development 52

Pharma Marketing Network

FEBRUARY 22, 2023

If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged. Marketing in the era of consumer-driven healthcare requires new tools and techniques. Plus, given today’s budget realities, you’re likely being asked to achieve more with less.

96

96

PharmExec

APRIL 27, 2023

Join host Fran Pollaro as he delves into the world of patient-centric dermatology innovations with Arcutis president and CEO Frank Watanabe in this Pharmaceutical Executive Podcast episode.

52

52

pharmaphorum

NOVEMBER 12, 2021

Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes. The post Merck on trends in oncology: the pharmaphorum podcast appeared first on.

52

52

pharmaphorum

NOVEMBER 17, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. They also discuss patient experience data, how it can be collected and how pharmaceutical regulatory authorities view it today.

Cerner 52

Cerner 52

pharmaphorum

DECEMBER 16, 2020

Episode four of Kantar Health’s Health Heroes podcast tackles pharma’s rare disease challenges, the role of patient registries and hears a moving story about the rare genetic disorder Tay-Sachs disease. The podcast finishes up with an overview from Geneviève on the current outlook for rare diseases.

52

52

ALiEM - Pharm Pearls

NOVEMBER 3, 2023

Digital Impact Factor: A Quality Index for Educational Blogs and Podcasts in Emergency Medicine and Critical Care. You will need to create a free, 1-time login account. Reference Lin M, Phipps M, Chan TM, et al. Ann Emerg Med. 2023;82(1):55-65. doi: 10.1016/j.annemergmed.2023.02.011

Labelling 209

Labelling 209

Pharmaceutical Commerce

DECEMBER 5, 2023

In today’s podcast we talk with Ron Lacy, Vice President of Product and Innovation from UBC about how AI is changing the services in the patient services market.

40

40